STRS Ohio’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Buy |
18,300
+5,700
| +45% | +$409K | 0.01% | 589 |
|
|
2026
Q1 | $830K | Buy |
12,600
+300
| +2% | +$19.1K | ﹤0.01% | 770 |
|
|
2025
Q4 | $782K | Buy |
12,300
+1,700
| +16% | +$106K | ﹤0.01% | 800 |
|
|
2025
Q3 | $583K | Buy |
10,600
+3,000
| +39% | +$124K | ﹤0.01% | 961 |
|
|
2025
Q2 | $251K | Sell |
7,600
-2,800
| -27% | -$97.4K | ﹤0.01% | 1582 |
|
|
2025
Q1 | $418K | Hold |
10,400
| – | – | ﹤0.01% | 1280 |
|
|
2024
Q4 | $489K | Sell |
10,400
-1,400
| -12% | -$72.7K | ﹤0.01% | 1217 |
|
|
2024
Q3 | $623K | Sell |
11,800
-500
| -4% | -$27.9K | ﹤0.01% | 1120 |
|
|
2024
Q2 | $666K | Buy |
12,300
+2,400
| +24% | +$145K | ﹤0.01% | 1051 |
|
|
2024
Q1 | $694K | Buy |
9,900
+4,400
| +80% | +$340K | ﹤0.01% | 1056 |
|
|
2023
Q4 | $459K | Hold |
5,500
| – | – | ﹤0.01% | 1317 |
|
|
2023
Q3 | $162K | Hold |
5,500
| – | – | ﹤0.01% | 1624 |
|
|
2023
Q2 | $179K | Buy |
5,500
+1,200
| +28% | +$44.4K | ﹤0.01% | 1616 |
|
|
2023
Q1 | $151K | Hold |
4,300
| – | – | ﹤0.01% | 1657 |
|
|
2022
Q4 | $197K | Sell |
4,300
-4,500
| -51% | -$194K | ﹤0.01% | 1591 |
|
|
2022
Q3 | $426K | Buy |
8,800
+1,900
| +28% | +$91.4K | ﹤0.01% | 1384 |
|
|
2022
Q2 | $271K | Buy |
6,900
+6,400
| +1,280% | +$258K | ﹤0.01% | 1507 |
|
|
2022
Q1 | $18K | Hold |
500
| – | – | ﹤0.01% | 2054 |
|
|
2021
Q4 | $22K | Buy |
+500
| New | +$19.3K | ﹤0.01% | 2103 |
|
|
2016
Q3 | – | Sell |
-64,900
| Closed | -$678K | – | 1914 |
|
|
2016
Q2 | $615K | Buy |
64,900
+5,000
| +8% | +$41K | ﹤0.01% | 1171 |
|
|
2016
Q1 | $422K | Hold |
59,900
| – | – | ﹤0.01% | 1328 |
|
|
2015
Q4 | $626K | Sell |
59,900
-32,600
| -35% | -$320K | ﹤0.01% | 1154 |
|
|
2015
Q3 | $618K | Sell |
92,500
-11,900
| -11% | -$81.2K | ﹤0.01% | 1158 |
|
|
2015
Q2 | $701K | Buy |
104,400
+45,800
| +78% | +$300K | ﹤0.01% | 1156 |
|
|
2015
Q1 | $397K | Buy |
58,600
+55,100
| +1,574% | +$411K | ﹤0.01% | 1267 |
|
|
2014
Q4 | $28K | Hold |
3,500
| – | – | ﹤0.01% | 1669 |
|
|
2014
Q3 | $12K | Hold |
3,500
| – | – | ﹤0.01% | 1756 |
|
|
2014
Q2 | $17K | Hold |
3,500
| – | – | ﹤0.01% | 1663 |
|
|
2014
Q1 | $33K | Buy |
+3,500
| New | +$31.7K | ﹤0.01% | 1648 |
|
|
2013
Q4 | – | Sell |
-11,100
| Closed | -$84K | – | 1755 |
|
|
2013
Q3 | $84K | Buy |
+11,100
| New | +$119K | ﹤0.01% | 1664 |
|
Other funds holding CYTK
ACA
STRS Ohio's CYTK Position: Q2 2026 in Review
STRS Ohio increased its Cytokinetics (CYTK) stake by 45% in Q2 2026, buying an estimated $409K and bringing the position to 18,300 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #589.
STRS Ohio first reported a position in CYTK in Q3 2013 and has held it in 30 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- STRS Ohio held 18,300 shares of Cytokinetics worth $1.56M as of Q2 2026.
- STRS Ohio bought 5,700 Cytokinetics shares in Q2 2026, an estimated $409K.
- Cytokinetics made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #589 holding.
- STRS Ohio first reported a position in Cytokinetics in Q3 2013 and has held it in 30 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.